Health Care & Life Sciences » Biotechnology | Cancer Genetics Inc.

Cancer Genetics Inc. | Mutual Funds

Mutual Funds that own Cancer Genetics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Extended Market Index Fund
179,351
0.65%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
68,198
0.25%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
31,225
0.11%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
29,432
0.11%
0
0%
07/31/2018
Vanguard Balanced Index Fund
17,202
0.06%
0
0%
07/31/2018
Vanguard Total Stock Market Index Fund
14,502
0.05%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
9,725
0.04%
0
0%
07/31/2018
6,547
0.02%
0
0.02%
09/05/2018
iShares Core S&P Total US Stock Market ETF
5,530
0.02%
0
0%
09/06/2018
Kaldi Capital, SICAV
2,998
0.01%
-4
0.06%
03/31/2018

About Cancer Genetics

View Profile
Address
Meadows Office Complex
Rutherford New Jersey 07070
United States
Employees -
Website http://www.cancergenetics.com
Updated 07/08/2019
Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S.